Activation of Hedgehog Pathway in Gastrointestinal Cancers

Ling Yang, Xiulan Su, Jingwu Xie

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The hedgehog (Hh) pathway is a major regulator for cell differentiation, tissue polarity, and cell proliferation in embryonic development and homeostasis in adult tissue. Studies from many laboratories reveal activation of this pathway in a variety of human cancer, including basal cell carcinomas (BCCs), medulloblastomas, leukemia, gastrointestinal, lung, ovarian, breast, and prostate cancers. It is thus believed that targeted inhibition of Hh signaling may be effective in treatment and prevention of human cancer. Even more exciting is the discovery and synthesis of specific signaling antagonists for the Hh pathway, which have significant clinical implications in novel cancer therapeutics. In this review, we summarize major advances in the past 2 years in our understanding of Hh signaling activation in human gastrointestinal cancer and their potential in clinical treatment with Hh pathway inhibitors.

Original languageEnglish
Pages (from-to)461-472
Number of pages12
JournalVitamins and Hormones
Volume88
DOIs
StatePublished - 2012

Fingerprint

Gastrointestinal Neoplasms
Neoplasms
Medulloblastoma
Basal Cell Carcinoma
Ovarian Neoplasms
Embryonic Development
Cell Differentiation
Lung Neoplasms
Prostatic Neoplasms
Leukemia
Homeostasis
Cell Proliferation
Breast Neoplasms
Therapeutics

Keywords

  • Gastrointestinal cancer
  • Hedgehog
  • Human cancer
  • Inhibitor
  • Therapy

ASJC Scopus subject areas

  • Endocrinology
  • Physiology

Cite this

Activation of Hedgehog Pathway in Gastrointestinal Cancers. / Yang, Ling; Su, Xiulan; Xie, Jingwu.

In: Vitamins and Hormones, Vol. 88, 2012, p. 461-472.

Research output: Contribution to journalArticle

Yang, Ling ; Su, Xiulan ; Xie, Jingwu. / Activation of Hedgehog Pathway in Gastrointestinal Cancers. In: Vitamins and Hormones. 2012 ; Vol. 88. pp. 461-472.
@article{0869383176064468a89faa5c33e2dc40,
title = "Activation of Hedgehog Pathway in Gastrointestinal Cancers",
abstract = "The hedgehog (Hh) pathway is a major regulator for cell differentiation, tissue polarity, and cell proliferation in embryonic development and homeostasis in adult tissue. Studies from many laboratories reveal activation of this pathway in a variety of human cancer, including basal cell carcinomas (BCCs), medulloblastomas, leukemia, gastrointestinal, lung, ovarian, breast, and prostate cancers. It is thus believed that targeted inhibition of Hh signaling may be effective in treatment and prevention of human cancer. Even more exciting is the discovery and synthesis of specific signaling antagonists for the Hh pathway, which have significant clinical implications in novel cancer therapeutics. In this review, we summarize major advances in the past 2 years in our understanding of Hh signaling activation in human gastrointestinal cancer and their potential in clinical treatment with Hh pathway inhibitors.",
keywords = "Gastrointestinal cancer, Hedgehog, Human cancer, Inhibitor, Therapy",
author = "Ling Yang and Xiulan Su and Jingwu Xie",
year = "2012",
doi = "10.1016/B978-0-12-394622-5.00020-1",
language = "English",
volume = "88",
pages = "461--472",
journal = "Vitamins and Hormones",
issn = "0083-6729",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Activation of Hedgehog Pathway in Gastrointestinal Cancers

AU - Yang, Ling

AU - Su, Xiulan

AU - Xie, Jingwu

PY - 2012

Y1 - 2012

N2 - The hedgehog (Hh) pathway is a major regulator for cell differentiation, tissue polarity, and cell proliferation in embryonic development and homeostasis in adult tissue. Studies from many laboratories reveal activation of this pathway in a variety of human cancer, including basal cell carcinomas (BCCs), medulloblastomas, leukemia, gastrointestinal, lung, ovarian, breast, and prostate cancers. It is thus believed that targeted inhibition of Hh signaling may be effective in treatment and prevention of human cancer. Even more exciting is the discovery and synthesis of specific signaling antagonists for the Hh pathway, which have significant clinical implications in novel cancer therapeutics. In this review, we summarize major advances in the past 2 years in our understanding of Hh signaling activation in human gastrointestinal cancer and their potential in clinical treatment with Hh pathway inhibitors.

AB - The hedgehog (Hh) pathway is a major regulator for cell differentiation, tissue polarity, and cell proliferation in embryonic development and homeostasis in adult tissue. Studies from many laboratories reveal activation of this pathway in a variety of human cancer, including basal cell carcinomas (BCCs), medulloblastomas, leukemia, gastrointestinal, lung, ovarian, breast, and prostate cancers. It is thus believed that targeted inhibition of Hh signaling may be effective in treatment and prevention of human cancer. Even more exciting is the discovery and synthesis of specific signaling antagonists for the Hh pathway, which have significant clinical implications in novel cancer therapeutics. In this review, we summarize major advances in the past 2 years in our understanding of Hh signaling activation in human gastrointestinal cancer and their potential in clinical treatment with Hh pathway inhibitors.

KW - Gastrointestinal cancer

KW - Hedgehog

KW - Human cancer

KW - Inhibitor

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84863230921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863230921&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-394622-5.00020-1

DO - 10.1016/B978-0-12-394622-5.00020-1

M3 - Article

VL - 88

SP - 461

EP - 472

JO - Vitamins and Hormones

JF - Vitamins and Hormones

SN - 0083-6729

ER -